Testosterone replacement therapy for bone loss prevention in HIV-infected males

Patrick G. Clay, Amy I. Lam, Lesbia Hernández, Denyse Demers

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


OBJECTIVE: To review the use of testosterone for the prevention of bone loss in men with HIV infection. DATA SOURCES: A MEDLINE search (1966-May 2002) on the use of testosterone in osteoporosis/HIV infection was performed. A reference bibliography search was also completed. DATA SYNTHESIS: Osteopenia/osteoporosis is reported in HIV-infected men due to a myriad of factors. Sex hormone deficiency is a frequent endocrine abnormality in this population. CONCLUSIONS: In HIV-negative men, testosterone may be beneficial for preventing bone loss and hastening the resolution of fractures. Testosterone's role in preventing bone loss in HIV-infected men remains to be defined.

Original languageEnglish
Pages (from-to)582-585
Number of pages4
JournalAnnals of Pharmacotherapy
Issue number4
StatePublished - 1 Apr 2003


  • AIDS
  • HIV
  • Osteopenia
  • Osteoporosis
  • Testosterone


Dive into the research topics of 'Testosterone replacement therapy for bone loss prevention in HIV-infected males'. Together they form a unique fingerprint.

Cite this